Vaccine Distribution: Opportunities and Pitfalls
Four Duke scholars examine logistics, vaccinating children and ensuring poor nations aren't left out
Topic Coronavirus
Duke scholars are working to advance our understanding of COVID-19, from basic science to translational medicine to clinical care—as well as to address concerns related to the pandemic from a variety of disciplines.
Top Story
Recent Stories
-
COVID-19 Vaccine Distribution Information for the Duke Community
Dear Duke Health and Duke University colleagues and staff: The FDA is planning to review the interim safety and efficacy data for the Pfizer/BioNTech COVID-19 vaccine on December 10th and the Moderna vaccine on December 17th as part of the process to consider COVID-19 vaccines for an emergency use authorization.
-
Some Triangle Hospitals Expecting to Have a COVID-19 Vaccine in as Few as 2 Weeks
Features comments by Dr. Joseph Rogers, chief medical officer for Duke Health
-
Rapid Testing for Children Barrels Ahead, Despite a Lack of Data
Quotes Dr. Ibukun Akinboyo, a pediatrician and infectious disease expert at Duke
-
Sign Over I-40 in Durham Could Damage Public Trust About Vaccine Process, Expert Says
Features comments by Thomas Denny, chief operating officer of Duke’s Human Vaccine Institute
-
‘All Hands on Deck’: How Duke and AI for Health Raced to Create a COVID-19 Solution for Patients
Featuring the work and comments of assistant professor of biomedical sciences Amanda Randles and her team at Duke
-
Texas Prepares for COVID-19 Vaccine
Interview with Dr. Mark McClellan, director of the Duke-Margolis Center for Health Policy
-
The COVID-19 Vaccine Will Require Multiple Doses. How Officials Plan to Ensure Compliance
Interview with Dr. Sarah Armstrong, a professor of pediatrics at Duke
-
Vaccine Institute’s Denny Co-Authors ‘How To’ Manual for College Campuses
Testing strategies against Covid-19 aren’t the only measure, but they’re most important
-
COVID-19 Vaccine Sign Hanging Over I-40 in Durham Worries Doctors
Features comments by Dr. Susanna Naggie, a clinical research expert at Duke University School of Medicine
-
Why Oxford’s COVID-19 Vaccine Could Do More for the World Than Other Shots
Features modeling by Duke University; quotes Andrea Taylor, assistant director of programs at the Duke Global Health Innovation Center
In the News
India Biggest Buyer of COVID-19 Vaccine With 1.6 Billion Doses
Cites an analyses from the Global Health Innovation Center
How Rich Countries Are ‘Hoarding’ The World’s Vaccines, In Charts
Quotes Andrea Taylor, who helps direct the Duke Global Health Innovation Center
Bipartisan Health Care Panel Is Cooper’s Pitch For Consensus
Quotes Duke-Margolis Center director Dr. Mark McClellan
NC Health Leaders Say ‘No Corners Cut’ With COVID-19 Vaccine Development
Quotes Dr. Thomas Holland, infectious disease doctor at Duke
States Prepare for Coronavirus Vaccine. The Logistics Get Complicated.
Quotes Thomas Denny, chief operating officer of the Duke Human Vaccine Institute
What to Do if You Can’t Find a Job
Quotes Fuqua School adjunct professor Dorie Clark
Ong Biauw Chi: The Front Liner Who Went Viral for Her Exemplary Leadership
Profiles the Duke-NUS Medical School clinical associate professor
Triangle Hospitals Brace for Holiday COVID-19 Surge Before the Vaccines Arrive
Quotes Dr. Cameron Wolfe, an infectious disease specialist at Duke University School of Medicine
What the Biden Team Needs to Do Now to Fight COVID-19
Commentary co-authored by Dr. Gavin Yamey, a physician, professor and director of Duke’s Center for Policy Impact in Global Health
North Carolina Judge Denies Request to Ban Pastor Accused of Being ‘Danger to Community’
Quotes Sarah Ludington, director of Duke Law’s First Amendment Clinic